Written by: William F. Fearon, M.D.Allen Jeremias, M.D.Guy Witberg, M.D., M.P.H.Rasha Al-Lamee, M.D., Ph.D.David J. Cohen, M.D.Amir Kaki, M.D.Rahul P. Sharma, M.D., M.B., B.S.Robert W. Yeh, M.D.Bassem M. Chehab, M.D.Michael C. Kim, M.D.Hiromasa Otake, M.D.Rajiv Tayal, M.D.Hitoshi Matsuo, M.D., Ph.D.Margaret McEntegart, M.D.Ankitkumar K. Patel, M.D., M.P.H.Yader Sandoval, M.D.Karim M. Al-Azizi, M.D.Kazuhiro Dan, M.D., Ph.D.Louai Razzouk, M.D., M.P.H.Stephane Fournier, M.D.Alexandra Popma, M.D.Jeffrey J. Popma, M.D.Duzhi Zhao, M.S.Bjorn Redfors, M.D., Ph.D.Mahesh V. Madhavan, M.D.Ran Kornowski, M.D.Martin B. Leon, M.D.Ajay J. Kirtane, M.D.
Find these authors on Roon
DC
Dr. David Cohen
Interventional & Structural Cards · Cardiovascular Research Foundation
AK
Dr. Ajay Kirtane
Interventional Cardiology · CUIMC
Summary
In a randomized trial, FFRangio (fractional flow reserve derived from angiography) was noninferior to pressure-wire–guided assessment in reducing risk among patients with intermediate coronary stenosis.
AK
Dr. Ajay Kirtane
Cardiology · Interventional CardiologyColumbia University Irving Medical CenterajayNew York City, NY, USA
